ArticleAging medicine (Milton (N.S.W))2025
Relationship Between Atherogenic Index of Plasma and Hypertension in Chinese Middle-Aged and Older Adults: A Cross-Sectional and Longitudinal Analysis Based on CHARLS.
Article in Aging medicine (Milton (N.S.W)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between the atherogenic index of plasma and prehypertension or hypertension among adults in Fujian, China: a population-based cross-sectional study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Atherosclerosis is the underlying pathology of cardiovascular disease (CVD), including hypertension. Unfortunately, the association between the atherogenic index of plasma (AIP) and hypertension has not been reported in a large-scale middle-aged and elderly population. This study aimed to evaluate the association between AIP and hypertension in a representative middle-aged and elderly population in China. Methods: The present study was a retrospective cohort study. We conducted cross-sectional and longitudinal analysis using data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018. Hypertension was identified by self-report or by taking antihypertensive medications. Participants aged below 45 years, with missing data on AIP, hypertension records, or taking lipid-lowering medication were excluded. Results: A total of 12,376 participants were included in the cross-sectional analysis; we found that after adjusting for covariates, each unit increment in AIP was associated with a 109.0% increased prevalence of hypertension (OR = 2.090, 95% CI: 1.776-2.459), a 41.2% increased likelihood of systolic blood pressure (SBP) above 140 mmHg (OR = 1.412, 95% CI: 1.199-1.664), and a 43.9% increased likelihood of diastolic blood pressure (DBP) above 90 mmHg (OR = 1.439, 95% CI: 1.153-1.795). A total of 5649 participants were included in the longitudinal analysis; we found that every one-unit increase in AIP was associated with a 57.7% increase in hypertension incidence (OR = 1.577, 95% CI: 1.282-1.941, Conclusions: These results demonstrated a significant positive association between AIP and the prevalence and incidence of hypertension in a nationwide representative middle-aged and elderly population in China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.